BioCentury
ARTICLE | Company News

ActoGeniX, Merck deal

November 19, 2012 8:00 AM UTC

ActoGeniX said it partnered with Merck to develop and validate an antibody therapy for an undisclosed indication using ActoGeniX's ActoBiotics drug delivery technology. ActoBiotics are oral capsules o...